
Cyproterone Acetate and Ethinylestradiol Tablets
2/0.035mg
Cyproterone acetate with ethinylestradiol as a film-coated tablet, used for severe acne, hirsutism and androgenetic alopecia. An anti-androgen with an oestrogen.
Severe acne involves widespread inflammation, deep nodules or cysts, or substantial scarring risk. Early clinical assessment can limit permanent marks and address the psychological burden.

2/0.035mg
Cyproterone acetate with ethinylestradiol as a film-coated tablet, used for severe acne, hirsutism and androgenetic alopecia. An anti-androgen with an oestrogen.
Catalogue matches do not establish acne severity or show that an oral retinoid or hormone treatment is suitable.
Follicle blockage, sebum, Cutibacterium acnes and inflammation interact. Hormones and genetics may contribute, but severe acne is not proof of poor hygiene or a specific diet. Picking or squeezing increases tissue damage.
A clinician may combine appropriate topical treatment with oral therapy and scar prevention. Isotretinoin has major fetal risk and other monitoring needs. Hormonal options are selected according to clot risk and individual health, not solely because acne occurs around cycles. See skin care.
Seek prompt care for rapidly worsening painful disease with fever, large areas of skin breakdown or severe mood change. Suspected pregnancy while taking isotretinoin requires immediate prescriber contact.